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Abstract 
Background Oral ulceration is a common, painful condition of uncertain aetiology. Ulcers are 
characterised by immune-mediated mucosal destruction, inflammation, and a proliferative healing 
phase. Oral ulceration is heritable but the genetic basis remains poorly characterised. We aimed to 
identify genetic risk factors for oral ulcers, and find evidence for a common genetic basis or causal 
association between oral ulceration and autoimmune traits.  
Methods A genome-wide association study was performed within the UK Biobank (UKBB) and 
replicated within the Avon Longitudinal Study of Parents and Children (ALSPAC). Outcome in UKBB, 
based on questionnaire data at recruitment (participants aged 40–73 years), was oral ulceration in 
the previous year. Outcome in ALSPAC, based on questionnaire data from a focus clinic (16–19 
years), was ever having oral ulceration. Bidirectional causal effects were estimated with two-sample 
Mendelian randomisation. 
Findings After exclusions and quality control measures, the genome-wide association study included 
119 959[PROD: small space glyph] individuals and 9 341 558 genetic variants. The genomic inflation 
factor (λ)[PROD: lambda] was 1·047. Replication included 2024 individuals. For ulcers, evidence for 
association was seen in or near IL12A1 (rs17753641, odds ratio 0·969 [95% CI 0·966–0·973], p=2·2E–
62 in discovery; 0·72, [0·56–0·92], p=0·01 replication), IL10 (rs3024490, 1·015 [1·012–1·018], p=1·1E–
25 in discovery; 1·42 [1·18–1·70], p=0·0001 replication), CCR3 (rs6441955,  p=2·4E-17 in discovery; 
unreplicated). Other variants were nominated in the discovery phase but not replicated in ALSPAC, 
including variants near HLA-DRB5 (rs11623911, p=1·1E-13), PPP5C (rs8106592, p=4·2E-10) and  IKZF1 
(rs9649738, p=2·2E-08).. When genotypes were used as a proxy for oral ulceration to investigate the 
impact of oral ulceration on autoimmune outcomes, evidence showed that oral ulceration reduced 
risk of Crohn’s disease (p=0·0037). In a genome-wide analysis no genetic correlation between ulcers 
and autoimmune traits was seen. 
Interpretation Variation in loci thought to regulate inflammatory function alters risk of oral 
ulceration. Oral ulceration appears to be a distinct inflammatory trait rather than a manifestation of 
other autoimmune diseases. The apparent protective effect of oral ulceration against Crohn’s 
disease is unexpected; this might be a biological effect—for example, divergence in inflammatory 
type could prevent both conditions from copresenting—or an artifactual finding. 
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